# California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA

> **NCT03469947** · PHASE3 · COMPLETED · sponsor: **Arrowhead Regional Medical Center** · enrollment: 200 (actual)

## Conditions studied

- Hemorrhagic Shock
- Trauma Injury

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03469947
- **Lead sponsor:** Arrowhead Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2024-07-29
- **Final completion:** 2024-07-29
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469947, "California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03469947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*